Most Recent
Wealth guru Dominque Grubisa wants the High Court to overturn a finding that she had actual knowledge her company's statements were misleading, saying the case raises unresolved questions about accessorial liability.
Radio manufacturer Hytera wants the High Court to hear its appeal of a finding that it misappropriated Motorola's source code in a case of "substantial industrial theft”.
Construction PRO
A recent High Court decision that dealt a blow to builders and developers in NSW will usher in a return to a pre-2002 litigation regime, when plaintiffs only sued the parties with the deepest pockets, an expert has told Lawyerly.
A creditor of defunct forestry giant Gunns Plantations has filed a High Court challenge after it didn't pay the company a $1.2 million judgment that confirmed the peak indebtedness rule does not apply in insolvency law.
Construction PRO
The valuer general of Victoria has told the High Court that a property in Melbourne's CBD should be valued at $6.2 million rather than $2.9 million, despite a heritage constraint on development.
Russian company UC Rusal wants the High Court to hear its appeal of an "extremely harsh" finding that Rio Tinto was entitled to refuse alumina deliveries due to export sanctions.
The Western Bulldogs, formerly the Footscray Football Club, has launched a High Court challenge to a $6 million award to a fan who was sexually abused by a club volunteer.
Construction PRO
Transport for NSW has asked the High Court to weigh in on when land is acquired for a 'public purpose', in a dispute over the value of land acquired near the Western Sydney Airport.
An Australian fashion designer has asked the High Court to overturn a Full Court win for singer Katy Perry in a long-running trade mark dispute, saying the court's findings “wrongly privilege the powerful and famous over ordinary traders”.
The High Court has settled a 16-year battle between the federal government and Sanofi over alleged excess subsidies it paid after a judge blocked the release of a generic version of blood thinner Plavix, saying its job was not to “resurrect” a dead case.